Transform Wealth LLC Sells 1,305 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Transform Wealth LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 15.9% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,900 shares of the medical equipment provider's stock after selling 1,305 shares during the period. Transform Wealth LLC's holdings in Intuitive Surgical were worth $3,417,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of ISRG. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Global Financial Private Client LLC increased its stake in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares during the last quarter. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $9.41 during mid-day trading on Thursday, reaching $513.00. The company had a trading volume of 2,390,381 shares, compared to its average volume of 1,668,728. The firm has a market cap of $183.87 billion, a price-to-earnings ratio of 80.03, a PEG ratio of 5.85 and a beta of 1.67. The business's 50-day simple moving average is $525.48 and its 200 day simple moving average is $538.67. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period last year, the firm posted $1.50 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president now owns 2,245 shares of the company's stock, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research analyst reports. Royal Bank of Canada dropped their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Truist Financial reduced their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Barclays cut their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.